News
CTKB
5.65
-1.40%
-0.08
Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis Tool
Barchart · 4d ago
Cytek BioSciences Inc Reaches Analyst Target Price
NASDAQ · 4d ago
Weekly Report: what happened at CTKB last week (0914-0918)?
Weekly Report · 6d ago
Weekly Report: what happened at CTKB last week (0907-0911)?
Weekly Report · 09/14 10:24
Sysmex Europe, Cytek Biosciences announce European collaboration
TipRanks · 09/09 13:00
Weekly Report: what happened at CTKB last week (0831-0904)?
Weekly Report · 09/07 10:18
Cytek Biosciences to Participate in Upcoming Investor Conferences
Barchart · 09/01 15:05
Weekly Report: what happened at CTKB last week (0824-0828)?
Weekly Report · 08/31 10:25
Cytek Biosciences Shares Drop After Jury Says It Owes $56 Million in Damages
Dow Jones · 08/24 14:09
Cytek Biosciences Faces Mixed Jury Verdict in Patent Case
TipRanks · 08/24 10:29
Weekly Report: what happened at CTKB last week (0817-0821)?
Weekly Report · 08/24 10:26
Cytek Biosciences Says Jury Finds In Cytek’s Favor On Three Of Four Asserted Patent Claims; To Challenge Remaining Finding; Jury Awarded Past Damages Consisting Of $20M In Lost Profits And $36M In Royalties
Benzinga · 08/21 20:41
Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding
Barchart · 08/21 15:35
Cytek Biosciences Balances Growth With Profit Pressures
TipRanks · 08/18 00:20
Weekly Report: what happened at CTKB last week (0810-0814)?
Weekly Report · 08/17 10:27
Weekly Report: what happened at CTKB last week (0803-0807)?
Weekly Report · 08/10 10:21
Cytek: Solid Q2 Beat and Modest Outlook Raise, But Regional and Profitability Risks Justify Hold Rating
TipRanks · 08/06 10:07
Cytek Biosciences GAAP EPS of -$0.09 in-line, revenue of $48.1M misses by $0.51M
Seeking Alpha · 08/05 21:31
Cytek Biosciences reports Q2 EPS (9c), consensus (2c)
TipRanks · 08/05 21:21
Cytek Biosciences sees FY26 revenue $207M-$212M, consensus $208.83M
TipRanks · 08/05 21:21
More
Webull provides a variety of real-time CTKB stock news. You can receive the latest news about Cytek Biosciences, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About CTKB
Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.